Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New program aims to ease emotional struggles for kids with leukemia

NCT ID NCT07587411

Symptom relief Sponsor: Zhengzhou University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is developing and testing a stepped-care program to help children with leukemia manage emotional and behavioral challenges like anxiety, sadness, and sleep problems. The program starts with simple support and adds more help as needed, including therapy sessions and parent training. The pilot trial will include 96 children aged 7-14 in Pakistan to see if the program is feasible and acceptable.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
stepped-care psychosocial intervention (psychoeducation, peer support, CBT, parent-child training, individualized therapy)
What this could lead to
If successful, this could provide a practical, low-cost way to support the mental health of children with leukemia in settings with limited resources.
What could go wrong
This is a small pilot study focused on feasibility, not on proving the intervention works. The results may not apply to other countries or healthcare systems.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 96 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2025

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

7 to 14 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Children diagnosed with leukaemia (confirmed by medical records). * Aged between 7 and 14 years at the time of diagnosis. * Primary carers (parents, guardians, or immediate family members) who are directly involved in the child's care and treatment. * Ability to comprehend and communicate in the local language (e.g., Urdu, Pashto). * Child in the stable remission or maintenance phase of leukaemia treatment. * Willingness to participate in the study and provide informed consent (child assent and parental consent). Exclusion Criteria: * Acute medical instability requiring intensive care. * Cognitive impairment preventing meaningful participation. * Severe mental health conditions (e.g., active psychosis, extreme depression) in the child. * Non-primary carers without direct responsibility for the child's care. * Active substance abuse or impairing conditions in the primary carer. * Non-English/non-Urdu/Pashto-speaking participants.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Childhood leukemia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

childhood leukemia leukemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Childhood leukemia

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hayatabad Medical Complex

    Peshawar, Khyber Pukhtoon Khwa, 25000, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.